Hemodialysis News, Research Articles | Kidney Dialysis Treatment Studies



Starting dialysis at a higher eGFR makes no difference in overall survival.

Dialysis Industry Unites In Wake of COVID-19 Pandemic

DaVita Inc. and Fresenius Medical Care North America (FMCNA) jointly announced they are collaborating in response to the COVID-19 pandemic to offer isolation capacity for dialysis patients who are or may be infected with the novel coronavirus that causes the disease. The companies, which are the largest providers of dialysis in the United States, also…

COVID-19 Surfaces in a US Hemodialysis Patient

Physicians at the University of California Irvine describe an unusual presentation of the novel coronavirus illness in a 56-year-old man. The case is believed to be among the first COVID-19 cases in the United States.
This image accompanies an article about how dialysis facilities are preparing to prevent infection with the COVID-19 coronavirus.

Dialysis Facilities Confront COVID-19

Dialysis facilities have stepped up precautions to protect patients with kidney failure from COVID-19, which can cause severe respiratory illness and death.

Gout Medication Safe, Effective in Dialysis Patients

Febuxostat is safe and effective for treating gout in patients on dialysis, according to a new study. The study was a retrospective review of clinical and laboratory data from 62 dialysis patients (45 on hemodialysis and 17 on peritoneal dialysis) with gout treated with febuxostat. The mean serum uric acid level decreased significantly from 9.36…
Dialysis Patients At Higher Cancer Risk

Twice-Weekly Hemodialysis Is Gaining Acceptance

Back in August 2012, I wrote a provocative editorial in this space titled, “How About Twice-Weekly Hemodialysis?” This was the first time the topic of dialysis provided less frequently than 3 times a week was brought up in the 21st century. I argued that because kidney function worsens gradually, dialysis treatment should be gradual and…

Dialysis Modalities Found to Offer Similar Survival

Patients starting on peritoneal dialysis or in-center hemodialysis have similar mortality risks, according to a new systematic review and meta-analysis of studies using propensity score matching to compare mortality risks between the modalities.
Next post in Hemodialysis